PHENOMEX INC (CELL) Stock Analyst Ratings
USA - NASDAQ:CELL - US0843101017 - Common Stock
0.9981 USD
+0 (+0.31%)
0.999 USD
+0 (+0.09%)
ChartMill assigns a Buy % Consensus number of 51% to CELL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.53. This target is 53.29% above the current price.
CELL was analyzed by 11 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about CELL.
In the previous month the buy percentage consensus was at a similar level.
CELL was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-23 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-08-22 | Berenberg | Downgrade | Buy -> Hold |
| 2023-08-18 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2023-05-12 | Stifel | Maintains | Hold |
PHENOMEX INC / CELL FAQ
What is the price target for CELL stock?
11 analysts have analysed CELL and the average price target is 1.53 USD. This implies a price increase of 53.29% is expected in the next year compared to the current price of 0.9981.
What is the consensus rating for PHENOMEX INC (CELL) stock?
The consensus rating for PHENOMEX INC (CELL) is 50.9091 / 100 . This indicates that analysts generally have a neutral outlook on the stock.